@prefix config: . @prefix meta: . @prefix rdf: . @prefix rdfs: . @prefix xsd: . @prefix owl: . @prefix dc: . @prefix dcmitype: . @prefix dcterms: . @prefix foaf: . @prefix geo: . @prefix om: . @prefix locn: . @prefix schema: . @prefix skos: . @prefix dbpedia: . @prefix p: . @prefix yago: . @prefix units: . @prefix geonames: . @prefix prv: . @prefix prvTypes: . @prefix doap: . @prefix void: . @prefix ir: . @prefix ou: . @prefix teach: . @prefix time: . @prefix datex: . @prefix aiiso: . @prefix vivo: . @prefix bibo: . @prefix fabio: . @prefix vcard: . @prefix swrcfe: . @prefix frapo: . @prefix org: . @prefix ei2a: . @prefix pto: . ou:bibtex "@article{Agundez2025,title = {Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy},journal = {Clinical Pharmacology and Therapeutics},year = {2025},author = {Eadon, M.T. and Hein, D.W. and Andersen, M.A. and Chapman, A.B. and Cooper-DeHoff, R.M. and Desta, Z. and Duarte, J.D. and Elchynski, A.L. and Gaedigk, A. and Karol, S.E. and Limdi, N.A. and Lteif, C. and Sosinski, L. and Zubiaur, P. and Whirl-Carrillo, M. and Klein, T.E. and Caudle, K.E. and Donnelly, R.S. and Ag{\\'u}ndez, J.A.G.}}"; dcterms:created "2025-12-01T00:00:00"^^xsd:dateTime; dcterms:contributor "Eadon M.T. et al."; bibo:issn "0009-9236"; bibo:volume "118"; dcterms:creator "Eadon M.T."; ou:eid "2-s2.0-105016631276"; vivo:identifier "2025-7026"; dcterms:title "Clinical Pharmacogenetics Implementation Consortium Guideline for NAT2 Genotype and Hydralazine Therapy"; ou:vecesCitado "2"^^xsd:integer; ou:openaccess "1"^^xsd:boolean; fabio:hasPublicationYear "2025"; ou:urlOrcid ; bibo:eissn "1532-6535"; bibo:doi "10.1002/cpt.70071"; ou:tipoPublicacion "Article"; a ou:Publicacion; dcterms:publisher "Clinical Pharmacology and Therapeutics"; ou:urlScopus ; vcard:url ; ou:publicadaEnRevista , . ou:tienePublicacion .